Ed Penhoet is listed as a director on 11 SEC Form D filings by 3 issuers between Jul 2009 and Apr 2015: aTYR PHARMA INC (San Diego, CA — biotechnology — 2015; $76.3M reported sold to 42 investors), Immune Design Corp. (Seattle, WA — biotechnology — 2009–2014; $48.5M reported sold to 8 investors) and SCYNEXIS INC (Durham, NC — pharmaceuticals — 2011–2012; $11.4M reported sold to 11 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as director, over about 6 years. Across those companies the filings report $136.2M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 11 public filings for Ed Penhoet and found 11 differences, 5 worth asking the sponsor about: Amount sold went down between filings; Investor count went down between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.